Chinese health biotech and the billion-patient market.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18183014.
- Also identified by DOI 10.1038/nbt0108-37 and PMC identifier 7096943.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.
Medical subject headings
- Biomedical Technology
- Biotechnology
- Delivery of Health Care
- Drug Industry
- Marketing of Health Services